Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 8Unknown 4Terminated 2Recruiting 2Withdrawn 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Sarcopenia 1Postoperative Complications 1Polycystic Ovary Syndrome 1Muscle Weakness 1Motor Activity 1Insulin Resistance 1Esophageal Neoplasms 1Body Weight 1

Interventions

Cyclophosphamide 240Radiotherapy 216Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Rituximab 141Capecitabine 141pembrolizumab 139Oxaliplatin 124Nivolumab 124Dexamethasone 122Fluorouracil 113fludarabine 103Radiosurgery 101Doxorubicin 99fludarabine phosphate 96Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 91Magnetic Resonance Spectroscopy 90Radiation 89Leucovorin 88Filgrastim 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × OTHER × Caloric Restriction × Clear all
NCT03676478 2025-12-10

EFECTS

University Hospital, Gasthuisberg

Phase NA Terminated
239 enrolled
Gastrointestinal

Esophageal Neoplasms, Postoperative Complications, Muscle Weakness, Sarcopenia

NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated
32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡